XML 17 R4.htm IDEA: XBRL DOCUMENT v3.7.0.1
Condensed Consolidated Statements of Income (Unaudited) - USD ($)
shares in Thousands, $ in Thousands
3 Months Ended
Mar. 31, 2017
Mar. 31, 2016
Net sales $ 500,051 $ 471,197
Cost of goods sold 230,064 207,168
Gross profit 269,987 264,029
Selling, general and administrative expense 194,940 189,716
Research and Development Expense 49,488 48,586
Segment profit (loss) 25,559 25,727
Interest expense 5,041 5,580
Foreign exchange losses, net 1,789 1,129
Other (income) expense, net (1,418) (1,177)
Income before income taxes 20,147 20,195
Provision for income taxes (7,734) (7,919)
Net income including noncontrolling interests 12,413 12,276
Net income attributable to Bio-Rad $ 12,413 $ 12,276
Basic earnings per share:    
Net income per share basic attributable to Bio-Rad $ 0.42 $ 0.42
Weighted average common shares - basic 29,580 29,364
Diluted earnings per share:    
Net income per share diluted attributable to Bio-Rad $ 0.41 $ 0.42
Weighted average common shares - diluted 29,911 29,506